Optimizing Patient Outcomes in IgAN: Expert Guidance on Evolving Management and Treatment Options

Learn more about emerging clinical data, guidelines, and regulatory approvals for patients with IgA nephropathy in this interactive text module. The program will feature patient perspective audio clips, a pathogenesis animation, expert-authored ClinicalThought commentaries, podcast episodes, and downloadable slides to provide an informed approach to optimizing patient outcomes in IgAN. 

Share

Program Content

Activities

Management of IgAN
Improving Outcomes in IgAN: Expert Guidance on Evolving Management and Treatment
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2024

Expires: June 30, 2025

Activities

Patient Outcomes in IgAN
Optimizing Patient Outcomes in IgAN: Expert Guidance on Evolving Management and Treatment Options
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2024

Expires: June 27, 2025

Activities

Care Gaps in IgA Nephropathy
Addressing Care Gaps in IgA Nephropathy: Expert Commentary on Optimizing Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2024

Expires: May 30, 2025

Faculty

cover img faculity

Andrew Bomback, MD, PhD

Associate Professor of Medicine
Division of Nephrology
Columbia University Medical Center
New York, New York

cover img faculity

Pietro Canetta, MD, MS

Associate Professor of Medicine
Division of Nephrology
Columbia University Irving Medical Center
New York, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in collaboration with American Kidney Fund

Supporters

Supported by educational grants from Novartis Pharmaceuticals Corporation and Otsuka America Pharmaceuticals.

Novartis Pharmaceuticals Corporation

Otsuka America Pharmaceuticals

Partners

American Kidney Fund

ProCE Banner